Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the current ratio high or low?
The current ratio of 4.07 is 63% below its 5-year average of 10.91, near the low end of its 5-year range (4.07–20.31).
As of the fiscal period ended Tuesday, June 30, 2026. 60.78% below its 12-month average of 10.38.
Reported quarterly current ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 4.07.
CURRENT RATIO
4.07
CURRENT RATIO AVG TTM
10.38
CURRENT RATIO AVG 3Y
10.76
CURRENT RATIO AVG 5Y
10.91
CURRENT RATIO AVG 10Y
N/A
CURRENT RATIO AVG 15Y
N/A
CURRENT RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
-60.78%
CURRENT VS 3Y AVG
-62.19%
CURRENT VS 5Y AVG
-62.70%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
3.75
median of 874 covered companies
CURRENT VS SECTOR MEDIAN
+8.53%
vs the sector median at left
Market Cap
$190.07M
Current Ratio
4.82
TTM Avg
7.13
3Y Avg
7.35
5Y Avg
8.24
Market Cap
$189.11M
Current Ratio
7.90
TTM Avg
9.91
3Y Avg
10.86
5Y Avg
18.34
Market Cap
$198.33M
Current Ratio
7.48
TTM Avg
9.04
3Y Avg
6.33
5Y Avg
4.86
Market Cap
$182.60M
Current Ratio
14.32
TTM Avg
7.65
3Y Avg
9.22
5Y Avg
9.58
Market Cap
$180.47M
Current Ratio
15.70
TTM Avg
3.42
3Y Avg
4.67
5Y Avg
3.16
| NAME | MARKET CAP | CURRENT RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| RxSight, Inc. (RXST) | $192.49M | 4.07 | 10.38 | 10.76 | 10.91 |
| Zentalis Pharmaceuticals, Inc. (ZNTL)vs › | $190.07M | 4.82 | 7.13 | 7.35 | 8.24 |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | 7.90 | 9.91 | 10.86 | 18.34 |
| Surrozen, Inc. (SRZN)vs › | $197.18M | 12.14 | 7.27 | 7.16 | 7.21 |
| Exagen Inc. (XGN)vs › | $197.87M | 3.18 | 3.08 | 4.43 | 6.31 |
| Cartesian Therapeutics, Inc. (RNAC)vs › | $198.33M | 7.48 | 9.04 | 6.33 | 4.86 |
| Alector, Inc. (ALEC)vs › | $200.96M | 5.26 | 3.62 | 4.54 | 4.95 |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | 14.32 | 7.65 | 9.22 | 9.58 |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | 15.70 | 3.42 | 4.67 | 3.16 |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | 11.22 | 14.99 | 15.44 | 13.43 |
Current Ratio
4.07
Quick Ratio
3.61
Current Ratio = Current Assets / Current Liabilities
The current ratio measures short-term liquidity — a company's ability to cover current liabilities with current assets. Above 1.0 indicates positive working capital.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | CURRENT RATIO |
|---|---|
| 2026-06-30 | 4.07 |
| 2026-03-31 | 10.20 |
| 2025-12-31 | 10.95 |
| 2025-09-30 | 12.74 |
| 2025-06-30 | 13.93 |
| 2025-03-31 | 12.68 |
| 2024-12-31 | 11.36 |
| 2024-09-30 | 12.67 |
| 2024-06-30 | 14.33 |
| 2024-03-31 | 9.20 |
| 2023-12-31 | 8.06 |
| 2023-09-30 | 8.87 |
| 2023-06-30 | 10.89 |
| 2023-03-31 | 12.62 |
| 2022-12-31 | 7.81 |
| 2022-09-30 | 8.50 |
| 2022-06-30 | 11.54 |
| 2022-03-31 | 15.12 |
| 2021-12-31 | 15.92 |
| 2021-09-30 | 20.31 |
| 2021-06-30 | 6.80 |
| 2021-03-31 | 11.35 |
| 2020-12-31 | 7.03 |
| 2020-09-30 | 0.00 |
| 2020-06-30 | 0.00 |
| 2020-03-31 | 0.00 |
